Total Payments
$17,338
2024 Payments
$981.98
Companies
38
Transactions
408
Medicare Patients
3,111
Medicare Billing
$322,334
Payment Breakdown by Category
Research$10,900 (62.9%)
Food & Beverage$6,405 (36.9%)
Education$33.05 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $10,900 | 6 | 62.9% |
| Food and Beverage | $6,405 | 400 | 36.9% |
| Education | $33.05 | 2 | 0.2% |
Payments by Type
Research
$10,900
6 transactions
General
$6,438
402 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| UCB Biosciences Inc. | $10,900 | 6 | $0 (2021) |
| ABBVIE INC. | $1,763 | 118 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $994.43 | 67 | $0 (2024) |
| UCB, Inc. | $669.73 | 33 | $0 (2023) |
| Janssen Biotech, Inc. | $552.24 | 30 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $421.55 | 33 | $0 (2024) |
| PFIZER INC. | $302.59 | 16 | $0 (2024) |
| Gilead Sciences, Inc. | $267.22 | 18 | $0 (2024) |
| Takeda Pharmaceuticals America, Inc. | $204.40 | 18 | $0 (2017) |
| Intercept Pharmaceuticals, Inc. | $148.10 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $981.98 | 50 | ABBVIE INC. ($204.65) |
| 2023 | $801.69 | 48 | AbbVie Inc. ($270.50) |
| 2022 | $977.94 | 59 | ABBVIE INC. ($319.55) |
| 2021 | $1,284 | 68 | UCB Biosciences Inc. ($250.00) |
| 2020 | $2,884 | 35 | UCB Biosciences Inc. ($2,350) |
| 2019 | $4,421 | 46 | UCB Biosciences Inc. ($3,700) |
| 2018 | $3,757 | 59 | UCB Biosciences Inc. ($2,900) |
| 2017 | $2,230 | 43 | UCB Biosciences Inc. ($1,700) |
All Payment Transactions
408 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/26/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/19/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZERBAXA | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/18/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 11/12/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: LIVER DISEASE | ||||||
| 10/30/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $25.79 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: Rare Disease | ||||||
| 10/21/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: Immunology | ||||||
| 09/23/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: IMMUNOLOGY | ||||||
| 09/23/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $10.96 | General |
| Category: IMMUNOLOGY | ||||||
| 09/11/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $20.42 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 09/04/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: IMMUNOLOGY | ||||||
| 08/27/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $20.73 | General |
| 08/21/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 08/13/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $9.60 | General |
| Category: IMMUNOLOGY | ||||||
| 08/05/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $26.68 | General |
| Category: Immunology | ||||||
| 07/30/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $32.12 | General |
| Category: IMMUNOLOGY | ||||||
| 07/23/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 07/22/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: Rare Disease | ||||||
| 07/16/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $13.62 | General |
| 07/15/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $24.41 | General |
| Category: Immunology | ||||||
| 07/12/2024 | CapsoVision, Inc. | CapsoCam Plus (Device) | Food and Beverage | Cash or cash equivalent | $24.68 | General |
| Category: Gastroenterology | ||||||
| 06/24/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $26.52 | General |
| Category: INTERNAL MEDICINE | ||||||
| 06/24/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Education | In-kind items and services | $13.76 | General |
| Category: INTERNAL MEDICINE | ||||||
| 06/18/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 06/10/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $26.69 | General |
| Category: Immunology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A Non-Interventional, Long term, Post-Marketing Registry of Patients Treated with Certolizumab Pegol (CIMZIA) For Crohn's Disease | UCB Biosciences Inc. | $8,550 | 4 |
| A Non-Interventional, Long term, Post-Marketing Registry of Patients Treated with Certolizumab Pegol CIMZIA For Crohn's Disease | UCB Biosciences Inc. | $2,350 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 604 | 620 | $403,319 | $59,948 |
| 2022 | 11 | 697 | 728 | $501,054 | $75,005 |
| 2021 | 14 | 925 | 967 | $665,804 | $97,255 |
| 2020 | 14 | 885 | 928 | $575,543 | $90,125 |
Total Patients
3,111
Total Services
3,243
Medicare Billing
$322,334
Procedure Codes
53
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45384 | Removal of polyps or growths of large bowel using a flexible endoscope with electrical cautery | Facility | 2023 | 83 | 83 | $111,303 | $14,182 | 12.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 97 | 105 | $31,080 | $8,886 | 28.6% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2023 | 58 | 60 | $30,900 | $6,795 | 22.0% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 33 | 33 | $31,515 | $5,673 | 18.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 66 | 67 | $66,933 | $4,355 | 6.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 42 | 42 | $10,668 | $4,112 | 38.5% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 31 | 31 | $35,154 | $4,004 | 11.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 33 | 33 | $12,639 | $3,679 | 29.1% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 42 | 42 | $36,036 | $3,405 | 9.4% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 15 | 15 | $19,350 | $2,380 | 12.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 29 | 30 | $3,600 | $2,171 | 60.3% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2023 | 75 | 79 | $14,141 | $306.33 | 2.2% |
| 45384 | Removal of polyps or growths of large bowel using a flexible endoscope with electrical cautery | Facility | 2022 | 116 | 116 | $155,556 | $19,565 | 12.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 116 | 135 | $39,080 | $12,266 | 31.4% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 56 | 56 | $53,480 | $9,870 | 18.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 104 | 107 | $106,893 | $7,991 | 7.5% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2022 | 63 | 66 | $33,990 | $7,059 | 20.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 60 | 60 | $22,276 | $6,950 | 31.2% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 16 | 17 | $19,278 | $2,334 | 12.1% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 25 | 25 | $21,450 | $1,906 | 8.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 21 | 24 | $2,880 | $1,839 | 63.8% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 17 | 17 | $4,318 | $1,777 | 41.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 16 | 16 | $3,312 | $1,690 | 51.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 19 | 19 | $26,011 | $1,525 | 5.9% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2022 | 68 | 70 | $12,530 | $233.78 | 1.9% |
About Dr. Kevin Beyer, D.O
Dr. Kevin Beyer, D.O is a Gastroenterology healthcare provider based in Kalamazoo, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1013970383.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kevin Beyer, D.O has received a total of $17,338 in payments from pharmaceutical and medical device companies, with $981.98 received in 2024. These payments were reported across 408 transactions from 38 companies. The most common payment nature is "" ($10,900).
As a Medicare-enrolled provider, Beyer has provided services to 3,111 Medicare beneficiaries, totaling 3,243 services with total Medicare billing of $322,334. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Kalamazoo, MI
- Active Since 04/08/2006
- Last Updated 03/19/2021
- Taxonomy Code 207RG0100X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1013970383
Products in Payments
- Cimzia (Drug) $11,570
- ENTYVIO (Biological) $512.21
- STELARA (Biological) $441.32
- Entyvio (Biological) $369.07
- RINVOQ (Biological) $356.91
- XIFAXAN (Drug) $304.14
- Humira (Biological) $269.08
- HUMIRA (Biological) $266.51
- SKYRIZI (Biological) $211.40
- Creon (Drug) $196.91
- REMICADE (Biological) $196.48
- TRULANCE (Drug) $154.16
- OCALIVA (Drug) $148.10
- CREON (Drug) $144.14
- Mavyret (Drug) $124.75
- LINZESS (Drug) $105.31
- INJECTAFER (Drug) $103.56
- Amitiza (Drug) $101.29
- OMVOH (Drug) $94.24
- ZENPEP (Drug) $93.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Kalamazoo
Dr. Brij Dewan, M.d, M.D
Gastroenterology — Payments: $10,677
Gastroenterology $10,677
Mark Kocab, Md, MD
Gastroenterology — Payments: $5,563
Gastroenterology $5,563
Dr. Tarun Sharma, M.d, M.D
Gastroenterology — Payments: $5,339
Gastroenterology $5,339
Dr. Aijaz Turk
Gastroenterology — Payments: $4,468
Gastroenterology $4,468
Eric Sieloff, Md, MD
Gastroenterology — Payments: $3,960
Gastroenterology $3,960
John Quertermus, M.d, M.D
Gastroenterology — Payments: $1,797
Gastroenterology $1,797